Questions about this study?
The HopeStage team will email you.
RecruitingNCT06809179
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
Medication studyAges 18–65United States
Understand this study
Who could participate?
This study is for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- Sherman Oaks, United States · Walnut Creek, United States and 7 more locationsSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo described in the protocol; its role is not resolved here
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 9, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- VistaGen Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06809179
- Official title
Show the full official title
A Phase 2, Three-arm, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol (PH94B) Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension
Recruitment & locations
RecruitingSherman Oaks · Walnut Creek · Largo
6 more locations
- Saint Charles
- Toms River
- Cary
- Cleveland
- Plymouth Meeting
- Plano
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is VistaGen Therapeutics, Inc.
Does this study involve medication?
Yes. The study involves medication, including Fasedienol Nasal Spray - Placebo Nasal Spray, Fasedienol Nasal Spray - Fasedienol Nasal Spray and Placebo Nasal Spray - Placebo Nasal Spray.
Who can participate?
This study is for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me